Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Advanced Life Sciences Holdings has entered into definitive securities purchase agreements to raise approximately $20 million of gross proceeds through a private placement of approximately 10.2 million shares of common stock and warrants to purchase approximately 5.1 million shares of common stock to a group of new and existing institutional investors.
Subscribe to our email newsletter
The purchase price for each share of common stock is $1.90 and the warrants are exercisable from the date of grant until the fifth anniversary of such date at an exercise price of $2.15 per share of common stock.
Lazard Freres & Co acted as the lead placement agent with Susquehanna Financial Group and CRT Capital Group acting as co-placement agents in the transaction.